These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 3117000)

  • 1. [Influence of angiotensin on the secretion of aldosterone in idiopathic hyperaldosteronism].
    Salvador M; Chamontin B; Rostaing L; Salva P
    Arch Mal Coeur Vaiss; 1987 Jun; 80(6):992-4. PubMed ID: 3117000
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [The application of captopril challenge test in the diagnosis of primary aldosteronism].
    Chen S; Zeng ZP; Song AL; Zhu L; Lu L; Tong AL; Shi C; Li HZ
    Zhonghua Nei Ke Za Zhi; 2017 Jun; 56(6):402-408. PubMed ID: 28592038
    [No Abstract]   [Full Text] [Related]  

  • 3. [Differences of blood plasma renin activity, angiotensin II and aldosterone levels in essential or secondary hypertension].
    Song AL; Zeng ZP; Tong AL; Lu L; Chen S; Li M; Fu CL; Wang YH; Sun ML
    Zhonghua Nei Ke Za Zhi; 2012 Apr; 51(4):294-8. PubMed ID: 22781950
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of angiotensin II and converting enzyme inhibitor (captopril) on blood pressure, plasma renin activity and aldosterone in primary aldosteronism.
    Mantero F; Fallo F; Opocher G; Armanini D; Boscaro M; Scaroni C
    Clin Sci (Lond); 1981 Dec; 61 Suppl 7():289s-293s. PubMed ID: 7032817
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Diagnostic value of the post-captopril test in primary aldosteronism.
    Castro OL; Yu X; Kem DC
    Hypertension; 2002 Apr; 39(4):935-8. PubMed ID: 11967253
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Primary hyperaldosteronism].
    Opocher G; Rocco S; Carpené G; Armanini D; Mantero F
    Minerva Endocrinol; 1995 Mar; 20(1):49-54. PubMed ID: 7651282
    [TBL] [Abstract][Full Text] [Related]  

  • 7. PTH Modulation by Aldosterone and Angiotensin II is Blunted in Hyperaldosteronism and Rescued by Adrenalectomy.
    Lenzini L; Prisco S; Vanderriele PE; Lerco S; Torresan F; Maiolino G; Seccia TM; Iacobone M; Rossi GP
    J Clin Endocrinol Metab; 2019 Sep; 104(9):3726-3734. PubMed ID: 30865228
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Converting enzyme inhibition with captopril in patients with primary hyperaldosteronism.
    Luderer JR; Demers LM; Harrison TS; Hayes AH
    Clin Pharmacol Ther; 1982 Mar; 31(3):305-11. PubMed ID: 6277545
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [The clinical use of captopril in the diagnosis and treatment of primary aldosteronism].
    Li J
    Zhonghua Xin Xue Guan Bing Za Zhi; 1990 Feb; 18(1):2-4, 60. PubMed ID: 2204520
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Captopril in primary hypertension. Effects related to the renin-angiotensin-aldosterone and kallikrein-kinin systems.
    Ohman KP; Karlberg BE; Nilsson OR; Wettre S
    Acta Med Scand Suppl; 1981; 646():98-105. PubMed ID: 7018190
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Renin and aldosterone secretion under converting enzyme inhibition].
    Nakamura K
    Nihon Naibunpi Gakkai Zasshi; 1983 Aug; 59(8):1099-116. PubMed ID: 6141075
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Increased adrenal sensitivity to angiotensin II in idiopathic hyperaldosteronism.
    Wisgerhof M; Carpenter PC; Brown RD
    J Clin Endocrinol Metab; 1978 Nov; 47(5):938-43. PubMed ID: 400738
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Abnormal adrenal responsiveness and angiotensin II dependency in high renin essential hypertension.
    Dluhy RG; Bavli SZ; Leung FK; Solomon HS; Moore TJ; Hollenberg NK; Williams GH
    J Clin Invest; 1979 Nov; 64(5):1270-6. PubMed ID: 500810
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Angiotensin-responsive aldosterone-producing adenoma masquerades as idiopathic hyperaldosteronism (IHA: adrenal hyperplasia) or low-renin essential hypertension.
    Gordon RD; Gomez-Sanchez CE; Hamlet SM; Tunny TJ; Klemm SA
    J Hypertens Suppl; 1987 Dec; 5(5):S103-6. PubMed ID: 2832571
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Detection of primary aldosteronism using the captopril test].
    Pirich K; Vierhapper H; Graninger W; Nowotny P; Waldhäusl W
    Wien Klin Wochenschr; 1987 Sep; 99(17):608-11. PubMed ID: 3314169
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The plasma aldosterone response to angiotensin II infusion in aldosterone-producing adenoma and idiopathic hyperaldosteronism.
    Wisgerhof M; Brown RD; Hogan MJ; Carpenter PC; Edis AJ
    J Clin Endocrinol Metab; 1981 Feb; 52(2):195-8. PubMed ID: 7462385
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Effect of inhibition of converting enzyme by captopril on arterial pressure, renin and aldosterone in essential hypertension].
    Posadas C; Sánchez G; Boyer JL; Delmar M; Serrano PA
    Arch Inst Cardiol Mex; 1982; 52(4):295-300. PubMed ID: 6291470
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of captopril on aldosterone response to potassium infusion in primary aldosteronism.
    Fallo F; Chouman M; Pagotto U; Pistorello M
    Miner Electrolyte Metab; 1991; 17(3):185-9. PubMed ID: 1779941
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Idiopathic hyperaldosteronism. A possible role for aldosterone-stimulating factor.
    Carey RM; Sen S; Dolan LM; Malchoff CD; Bumpus FM
    N Engl J Med; 1984 Jul; 311(2):94-100. PubMed ID: 6330549
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Activation of aldosterone secretion in primary aldosteronism.
    Spark RF; Dale SL; Kahn PC; Melby JC
    J Clin Invest; 1969 Jan; 48(1):96-104. PubMed ID: 4303791
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.